Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA
1.1.2 - 1.1.2 United States of America flag

Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.1.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc-fda/ and changes regularly. See the Directory of published versions

: eCTD Product Characterisation of Impurities Composition for TabletCoatedBeadsCoatedAll - JSON Representation

Raw json | Download


{
  "resourceType" : "Composition",
  "id" : "8a07e353-9cf6-4f27-8a30-2c2d4f439847",
  "meta" : {
    "profile" : [
      🔗 "http://hl7.org/fhir/us/pq-cmc-fda/StructureDefinition/ectd-composition-32p55"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Composition </b><a name=\"8a07e353-9cf6-4f27-8a30-2c2d4f439847\"> </a><a name=\"hc8a07e353-9cf6-4f27-8a30-2c2d4f439847\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceComposition &quot;8a07e353-9cf6-4f27-8a30-2c2d4f439847&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ectd-composition-32p55.html\">eCTD Product Characterisation of Impurities Composition</a></p></div><p><b>status</b>: final</p><p><b>type</b>: Product Characterisation of Impurities <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-pqcmc-comp-section-types.html\">Code System PQCMC Comp Section Types</a>#32P55)</span></p><p><b>date</b>: 2024-04-24 01:12:07+0000</p><p><b>author</b>: <a href=\"Bundle-9e8f2d16-66b1-47ec-878d-f50ae021985b.html#urn-uuid-98effc99-db2b-428d-89aa-0ce426e02788\">urn:uuid:98effc99-db2b-428d-89aa-0ce426e02788</a></p><p><b>title</b>: eCTD Product Characterisation of Impurities Composition for TabletCoatedBeadsCoatedAll</p></div>"
  },
  "status" : "final",
  "type" : {
    "coding" : [
      {
        "system" : "http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/pqcmc-comp-section-types",
        "code" : "32P55",
        "display" : "Product Characterisation of Impurities"
      }
    ]
  },
  "date" : "2024-04-24T01:12:07.108Z",
  "author" : [
    {
      "reference" : "urn:uuid:98effc99-db2b-428d-89aa-0ce426e02788"
    }
  ],
  "title" : "eCTD Product Characterisation of Impurities Composition for TabletCoatedBeadsCoatedAll",
  "section" : [
    {
      "title" : "Impurities for TabletCoatedBeadsCoatedAll",
      "entry" : [
        {
          "reference" : "urn:uuid:ddd3abad-347c-4d2f-95f3-dd804e250502"
        }
      ]
    }
  ]
}